Mechanisms of Drug Resistance in High-Grade Serous Ovarian Cancer
Author:
Funder
AstraZeneca
Roche Genentech
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference80 articles.
1. Rethinking ovarian cancer: recommendations for improving outcomes;Vaughan;Nat Rev Cancer,2011
2. Mucinous carcinomas of the ovary and colorectum: different organ, same dilemma;Kelemen;Lancet Oncol,2011
3. Clear cell carcinoma of the ovary: a review of the literature;del Carmen;Gynecol Oncol,2012
4. Pathogenesis and heterogeneity of ovarian cancer;Kroeger;Curr Opin Obstet Gynecol,2017
5. Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer;Bowtell;Nat Rev Cancer,2015
Cited by 99 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Dysregulated Cholesterol Metabolism with Anomalous PI3K/Akt/mTOR pathway Predicts Poor Carboplatin Response in High Grade Serous Ovarian Cancer;2024-08-19
2. Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer;JOVE-J VIS EXP;2024
3. Ovarian cancer: Diagnosis and treatment strategies (Review);Oncology Letters;2024-07-18
4. Comprehensive analysis of hub genes associated with cisplatin-resistance in ovarian cancer and screening of therapeutic drugs through bioinformatics and experimental validation;Journal of Ovarian Research;2024-07-10
5. Predictive modeling of gene mutations for the survival outcomes of epithelial ovarian cancer patients;PLOS ONE;2024-07-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3